Royal Foods

9 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• MFRHACCP3 refused lines

  Seafood HACCP requirements not met

  The seafood appeared to have been processed without meeting the seafood HACCP requirements in 21 CFR 123.6(a) and 123.8(a), so it is treated as prepared under insanitary conditions.

• NO PROCESS3 refused lines

  No scheduled process filed

  The manufacturer appeared not to have filed a scheduled process with FDA, which 21 CFR Part 108 requires for low-acid canned and acidified foods, so the product is treated as made under insanitary conditions.

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

Questions about Royal Foods

Is Royal Foods on an FDA import alert?

Yes. As of October 26, 2026, Royal Foods is on the red list of FDA Import Alert 16-119, “Fish products from importer and processor combinations”, for sardines in tomato sauce; FDA published the listing on February 20, 2018.

Has FDA refused shipments from Royal Foods?

Yes. FDA refused 6 shipment lines from Royal Foods between April 27, 2018 and February 4, 2025. The most recent, on February 4, 2025, was sardines (brisling, sprats, pilchards, etc.), charged as NUTRIT LBL (nutrition information missing from label).

Why did FDA refuse Royal Foods's shipments?

The most frequent charges are MFRHACCP (seafood haccp requirements not met, 3 lines) and NO PROCESS (no scheduled process filed, 3 lines).

When was Royal Foods last inspected by FDA?

FDA's most recent inspection of Royal Foods with a final classification is dated May 23, 2016 and was classified VAI (Voluntary Action Indicated).

What is Royal Foods's FEI number?

Royal Foods's FDA Establishment Identifier (FEI) is 3005425398.

Can shipments from Royal Foods still enter the U.S.?

Shipments of sardines in tomato sauce from Royal Foods can be detained without physical examination under Import Alert 16-119; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).